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Background: Breast cancer is becoming a public health problem in Vietnam. The mortality to incidence ratio
of the disease was ranked second among the most common cancers in women. This study estimates the
survival probability at 1, 3, and 5 years following diagnosis and determines prognostic factors for breast
cancer mortality in Vietnam.
Methods: A survival analysis was conducted based on retrospective data from Hue Central Hospital and the
Cancer Registry in Ho Chi Minh City. Using the Kaplan-Meier method, the survival probability of patients
with breast cancer was estimated at 1, 3, and 5 years following diagnosis. The covariates among prognostic
factors for survival time were studied using an extended Cox proportion hazards model, including time-
dependent predictors.
Results: Overall survival rates at 1, 3, and 5 years following diagnosis were 0.94, 0.83 and 0.74 respectively.
Marital status, education level, stage at diagnosis, and hormone therapy were prognostic factors for mortality.
For the stage at diagnosis, the relation to the risk of death for breast cancer was 1.32 (95% CI, 1.221.41).
Married women faced a risk of death nearly 1.59 times higher than unmarried women (95% CI, 1.092.33).
Women with higher levels of education and who received hormone therapy had approximately 10% (hazard
ratio [HR]: 0.92; 95% CI, 0.890.96) and 80% (HR: 0.22; 95% CI, 0.120.41) risk reduction of death
respectively, compared with those classified as illiterate and those without hormone therapy.
Conclusions: The 5-year survival probability of breast cancer was lower in Vietnam than in countries with
similar distributions of the stage at diagnosis. Screening programs and related support policies should be
developed to increase the life expectancy of women with breast cancer in Vietnam.
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B
reast cancer is the most common cancer among
women, with more than 1.1 million women newly
diagnosed globally every year. Death from breast
cancer accounts for 1.6% of female deaths every year
worldwide (1). The mortality rates of breast cancer vary
among different communities and countries. The 5-year
overall survival rate tends to be lower in developing
countries (2, 3). The relationship between survival time
and stage at diagnosis is consistent in the literature (47).
Detection at an earlier stage of the disease and better
access to effective treatment have been recommended
as solutions to improve the life expectancy of breast
cancer patients (3, 8). Other prognostic factors, such as
demography, socioeconomics, hormone receptors, and
psychology, were found to have varying effects on breast
cancer survival rates in different studies (914).
The breast cancer incidence in Vietnam has increased
steadily over the last decade from a crude rate of 13.8 per
100,000 women in 2000 to 28.1 per 100,000 women in
2010, with an estimated 12,533 breast cancer cases in the
country (15). The mortality to incidence ratio of breast
cancer was 0.44, ranked second in mortality of common
cancers in Vietnamese women in 2002 (16). Previous
studies in Vietnam estimated the overall 5-year survival
rate to be 85.1%; this rate varied with the stage of breast
cancer. The prognostic factors, the hormonal receptors,
such as estrogen receptor (ER), progesterone receptor
(PR), and hormone therapy, were reported inconsistently
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in these studies (17, 18). While previous studies investi-
gated survival time only for specific patient groups such
as premenopausal breast cancers with/without positive
hormone receptors or patient groups who received
supportive treatment with chemotherapy and/or hor-
mones, the present study used a more general sample
and included demographic factors not previously consid-
ered in Vietnam. The objectives of the study were to
estimate the survival probability at 1, 3, and 5 years,
following diagnosis of breast cancer patients, and to
determine the effects of age, ethnicity, stage at diagnosis,
marital status, educational level, type of primary treat-
ment, and hormone therapy on mortality of breast
cancer in Vietnam. The results of the study could help
health policy makers engaged in planning for breast
cancer interventions and can be used in models of cost-




The study was conducted in Ho Chi Minh City and
Thua Thien Hue province. Ho Chi Minh City in the
South of Vietnam is the largest economic center in the
country and the most crowed city, with a population
of 7,196,100 in 2009 (19). The Ho Chi Minh Cancer
Registry, a population-based cancer registry established
in 1990, is one of the two cancer registries in Vietnam
recognized by the International Association of Cancer
Registries (IACR) (20, 21). Thua Thien Hue province
is located in central Vietnam; its capital, Hue City, is
famous as a cultural center of the country. The province
had 1,087,600 people in 2009 (19). Hue Central Hospital
is responsible for a cancer registry covering all provinces
in the central region. It was established in 2000 and
developed into a population-based cancer registry in
2008. These cancer registries do not include data on
follow-up or death certificates of cancer patients (20).
Breast cancer is the most common cancer among women
in both study settings with the age standardized rate
(ASR) of the disease estimated at 21/100,000 in Ho Chi
Minh City and 11.9/100,000 in Thua Thien Hue province
between 2004 and 2008 (22).
Data source and subjects
The morbidity data of the study came from the Ho Chi
Minh Cancer Registry and the medical record reviews
from Hue Central Hospital.
Inclusion criteria: all cases of female breast cancer with
code of C 50 (ICD-10 version) (23) who met the following
criteria were included in the study: age between 35 and
75 years; diagnosis with primary breast cancer in the
period 20012006; resident of Ho Chi Minh City or Thua
Thien Hue province; staging at diagnosis based on tumor/
nodes/metastasis staging system (TNM) of the Union for
International Cancer Control (UICC) (24).
A total of 1,584 cases of breast cancer were eligible for
the study. This included 1,427 cases registered between
2003 and 2006 in Ho Chi Minh City. The remaining 157
cases were diagnosed between 2001 and 2006 in Thua
Thien Hue province. Secondary data from the Cancer
Registry in Ho Chi Minh City, and medical records in Hue
Central Hospital provided information on age, ethnic
group, date of diagnosis, stage at diagnosis, and the
primary treatment following diagnosis. Those patients
would be on the track in their community until December
31, 2010. The result of follow-up left 948 patients or their
relatives (if the patients were deceased) available for direct
interview. There was incomplete follow-up data for 636
patients (40.2%). The most common reason for incom-
plete follow-up was migration, particularly in Ho Chi
Minh City. Population shifts are understandable in the
biggest and the most crowded city in Vietnam. The data in
Table 1 compare the characteristics between the two
groups of patients, with and without loss to follow-up.
There was no statistically significant difference in most
characteristics of breast cancer patients between these
two groups (p0.05). The exception was the primary
treatment received. However, this difference was small
(p0.039). The group lost to follow-up was excluded
from the survival analysis in the study.
Follow-up information was obtained from direct inter-
views of 948 patients or their relatives, using structured
questionnaires. Information on marital status, educa-
tional level, hormone therapy during 5 years, patient’s
status (alive or dead), date of death, and causes of death
were collected for each patient.
Prognostic factors
We examined the effects of ethnic group, age, marital
status, educational level, stage at diagnosis, type of
Policy recommendations from the study
. An early detection strategy for breast cancer should be developed to improve life expectancy of women with
breast cancer in Vietnam.
. Breast cancer education and awareness should be supported hand in hand with early detection programs.
. Financial support policies should be considered to promote access of women to appropriate diagnosis and
treatment, particularly for the most economically disadvantaged.
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primary treatment and hormone therapy on survival time
of breast cancer patients.
Ethnicity in the sample was classified as majority
(Kinh) or minority (primarily Chinese). The age variables
were stratified into five groups: aged B40; 4049; 5059;
6069; ]70. Marital status was recorded as married or
unmarried. Unmarried women included those who had
never married before they were diagnosed with breast
cancer. Educational level was categorized into five groups:
illiterate; primary school; secondary school; high school
and junior college, or higher. Stage at diagnosis (clinical or
pathological) was analyzed as stage 0 (in situ); stage I,
stage II (including stage IIA and stage IIB), stage III
(including stage IIIA and stage IIIB), and stage IV.
Because so few patients presented with stage 0, stage I
and stage 0 were combined for the analysis. Primary
treatment was classified into one of five categories based
on the initial treatment received following diagnosis.
The treatment categories were surgery, radiotherapy,
chemotherapy, hormone therapy, and no treatment (treat-
ment was not received or was unknown). Patients or their
relatives’ recall of prescriptions for Tamoxifen or similar
medication during the 5 years after primary treatment was
used as an indicator of hormone treatment in this study.
Statistical analysis
The survival duration of each case was determined as
the difference in time (months) between the date of
initial diagnosis until the date of death (by breast cancer
only), or the closing date of follow-up. Death by other
causes was considered censored results in the study.
Potential follow-up time ranged from 4 to 10 years. The
overall survival of patients with breast cancer at 1, 3,
and 5 years, following diagnosis was calculated by the
Kaplan-Meier method. A Cox regression model was
used to examine the effects of characteristics of patients
and treatments on survival time. The following variables
were included in the model as predictors: ethnic group,
age group, marital status, education level, stage at
diagnosis, primary treatment, and hormone therapy.
A goodness-of-fit (GOF) test was conducted to assess
the proportional hazard (PH) assumptions of the Cox
model for given predictor variables (Table 2). The
findings indicated that variable education level and
variable stage at diagnosis did not satisfy PH assump-
tions (pB0.05). We therefore fitted the extended Cox
model in which these variables were analyzed as time-
dependent variables (25).
In addition, the possible interaction effects of educa-
tion level, marital status, hormone therapy, and primary
treatments with stage at diagnosis were considered in this
full model.
The formula for the extended Cox model for time-
dependent variables was applied as following:









h(t, Xi, Xj(t)) is Hazard function*expresses the hazard
at time t for an individual with a given specification of
set of time-independent predictor variables and time-
dependent predictor variables.
ho(t) is Baseline hazard function.
Table 1. Characteristics of breast cancer patients for groups


















Stage 0 0.42 0.94
Stage I 10.76 11.01 0.094
Stage II 61.18 57.08
Stage III 19.41 24.21
Stage IV 8.23 6.76
The primary treatment
Surgery 78.69 72.96
Radiation 0.42 0.94 0.039
Chemotherapy 10.55 11.32
Hormone therapy 0.11 0.31
No treatment 10.23 14.47
*Pearson chi-square.
Table 2. Goodness-of-fit test assessing proportional hazards
assumption
Predictors rho* Chi-square test df** p
Ethnic group 0.06846 1.28 1 0.2571
Age group 0.03237 0.29 1 0.5871
Marital status 0.02643 0.19 1 0.6619
Education level 0.16793 7.48 1 0.0062
Stage at diagnosis 0.33341 27.11 1 0.0000
Primary treatment 0.09538 2.76 1 0.0967
Hormone therapy 0.11012 3.12 1 0.5871
Global test 38.11 7 0.0000
*The correlation coefficient between the residuals and time.
**Degree of freedom.
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Xi denotes the ith time-independent predictor variable.
Xj(t) denotes jth time-dependent predictor variable.
p1Xi is the entire collection of time-independent
predictors (including variables, namely ethnic, married,
treatment, hormone, age in the study).
p2Xj(t) is the entire collection of time-dependent
predictors at time t (including variables stage(t), educa-
tion(t), treatment*stage(t), married*stage(t), education*
stage(t), hormone*stage(t) in the study).
ßi: regression coefficient for time-independent predic-
tor variables.
dj: regression coefficient for time-dependent predictor
variables.
Model assumes that hazard at the time t depends on
the value of Xj (t) at the same time.










This formula describes the ratio of hazards at a par-
ticular time t that compares two specifications of
time-independent predictors (X* and X) and those of
time-dependent predictors at time t (X*(t) and X(t)). The
coefficient d represents the overall effect of the corre-
sponding time-dependent variables, considering all times
at which this variable has been measured in the study
(25).
A reduced extended Cox model was then carried out by
excluding interaction terms that were not statistically
significant. In the final model, the prognostic factors that
showed statistically significant effects were analyzed
according to subgroups to determine the effect of each
stratum on survival time for breast cancer patients.
A p-value of less than 0.05 was considered statistically
significant.
Results
Study subject characteristics are reported in Table 3.
The mean age of patients at the time of diagnosis was
50 years. The most frequent age group was that from 40
to 49 years (43% of the patients). Most the women were
married (83.1%). The education level of the study
population was low, with 30.1 and 27.8% of women
having completed primary school and secondary school,
compared with 26.4 and 11.5% of those having attended
high school and higher levels. Among the women, 4.2%
were illiterate. The majority of the women had been
diagnosed with breast cancer at stage II at primary
diagnosis (61.2%). Late stage diagnosis (stage III and
stage IV) was also considerable, making up 19.4 and 8.2%
of the study population, respectively. Surgery was the
most common treatment for patients following diagnosis
with breast cancer (78.7%). Significantly, 10.2% of all the
patients did not receive any type of primary treatment
and 10.6% of cases were treated with chemotherapy after
diagnosis. There were 74.6% of cases who reported
receiving hormone therapy during 5 years following the
primary treatment.
The overall survival rate declined over time and was
estimated to be 0.94, 0.83, and 0.74 at 1, 3, and 5 years,
respectively, following diagnosis for breast cancer (Fig. 1).
The findings in Table 4 show evidence of interaction
between hormone therapy and stage at diagnosis on the
survival time (p0.023), but there was no significant
interaction effect between primary treatment, marital
status, education level, and stage on risk of death for
breast cancer cases in this study (p0.05). Estimates of
the regression coefficients for time-dependent variables
indicate that the death hazard decreases with education
Table 3. Characteristics of patients with breast cancer
Characteristics Number of patients Percent
Ethnic group
Majority group 894 94.3
Minority group 54 5.7
Age at diagnosis












Primary school 285 30.1
Secondary school 264 27.8
High school 250 26.4
Higher 109 11.5
Stage at diagnosis
Stage 0 and I 106 11.2
Stage II 580 61.2
Stage III 184 19.4





Hormone therapy 1 0.1
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level and increases with the stage at diagnosis (Table 4).
The results from the extended Cox model analysis,
excluding insignificant interaction terms, revealed four
characteristics that had prognostic value for survival
probability for breast cancer, including marriage (p
0.016), education level (pB0.001), stage at diagnosis
(pB0.001), and hormone therapy (pB0.001) (Fig. 2).
Marital status had the strongest effect on risk of death,
with HR of 1.59 (95% CI: 1.09 to 2.33), followed by
stage at diagnosis (HR: 1.32; 95% CI: 1.22 to 1.41).
A later stage of breast cancer and the status of ‘married’
were related to poor prognosis for survival probability.
In contrast, a higher education level and hormone
therapy reduced mortality, with HR of 0.92 (95%
CI: 0.89 to 0.96) and HR of 0.22 (95% CI: 0.12 to
0.41), respectively.
A further analysis of these prognostic factors is shown
in Table 5. The hazard ratio for stage IV was 2.27 times
higher than that for stage I. Married women faced nearly
60% higher risk of death than unmarried women. Women
with an education level of high school and higher and
women who had received hormone therapy reduced risk
of death by approximately 10 and 80%, respectively,
compared with those classified as illiterate and those
without hormone therapy.
Discussion
The study showed similarities in the epidemiology
of breast cancer in Vietnam and other Asian countries.
The disease was most common in women aged between
40 and 49, while in the West incidence peaks among
women aged between 60 and 70 years (13). The majority
of women in the study population were newly diagnosed
at stage II of breast cancer, whereas 6070% of cases in
developed countries were detected at earlier stages (stage
I and stage 0) (1, 2). Consequently, surgery was the most
common primary treatment in the study. Mastectomy or
conserving surgery and/or axillary dissection are the
favored treatments for breast cancer patients at early
stages (stage I and stage II) in almost all countries (2).
The survival probability of breast cancer in this study
population decreased with time from initial diagnosis.
Overall survival rates at 1, 3, and 5 years in our study
were higher than those in a similar study from Chennai
(known as previous Madras), India, in 1997, at 94; 83,
and 74% versus 80, 58, and 48%, respectively (6). The
5-year overall survival of the study population was also
higher than that of Uganda (56%) in 2008 (5). However,
the rate revealed in the study was rather lower than
those in other Asian countries, such as China (76.5%),
Taiwan (78.37%), Japan (76.186.1%), and South Korea
(83.5%) (2, 7), and even lower than previous results in
North Vietnam (85.1%) (17, 18). This figure is still lower
when compared with Western countries such as Sweden
(89%), Canada (86%), and the United States (88%) (2).
Among prognostic factors, those who were diagnosed
at a higher stage demonstrated a poor prognosis for
survival time. This result is consistent with previous
findings in many studies all over the world (47, 26). One
reason for the lower survival rate in our study is the late
stage at which breast cancer is detected compared to
developed countries (2). Moreover, the absence of pri-
mary treatment for 10.2% of the study population
compared with previous studies in Vietnam, in which
all patients received standard treatment after diagnosis,
may explain the poorer survival rate of breast cancer
Fig. 1. Overall survival rate at 1, 3, and 5 years following
diagnosis for breast cancer.
Table 4. Extended Cox model, including patient
characteristics and interaction terms
Hazard ratio p 95% CI
Ethnic group 1.01 0.961 0.611.67
Marital status 2.41 0.093 0.866.74
Primary treatment 0.89 0.542 0.611.30
Hormone therapy 0.22 0.000 0.120.40
Age group 1.11 0.100 0.981.25
Education level* 0.86$ 0.034 0.760.99
Stage at diagnosis* 1.25% 0.019 1.041.51
Primary treatmentstage** 1.02 0.235 0.991.06
Marital statusstage** 0.95 0.367 0.851.06
Education levelstage** 1.03 0.325 0.981.08
Hormone therapystage** 1.08 0.023 1.011.16
95% CI: 95% confidence interval for hazard ratio.
*Variables continuously vary with respect to time.
**Interaction terms defined as the product of primary treatment,
marital status, education level, hormone therapy, and stage at
diagnosis.
$Estimate of regression coefficient for variable education level
is 0.14.
%Estimate of regression coefficient for variable stage at diagnosis
is 0.22.
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patients in this study. Lack of appropriate treatment
could also be the reason for the higher mortality in our
study compared to other Asian countries with the same
stage distribution at diagnosis (35, 26). Indeed, although
there have been many efforts in cancer control in
Vietnam, these activities have only met 15% of demand.
The country is facing a lack of infrastructure, equipment,
and human resources in oncology. Programs for the early
detection of breast cancer have not yet been implemented
nationwide. Cancer awareness in the community is still
low. These are the main reasons for presentation at
hospital with late stages of cancer. In addition, most
facilities with capacity to treat cancer are located in a few
big cities; hence, most cancer patients must be referred to
the central level (27). Our findings suggest that early
detection of breast cancer along with the availability and
accessibility of appropriate treatment should be recom-
mended to improve life expectancy for women with the
disease in Vietnam.
Being married appeared as the most unfavorable
prognostic factor for survival probability for women
with breast cancer in our study. A review by Falagas
et al. (2007) showed that the effect of marital status on
breast cancer outcome varied across studies (9). The
benefits of emotional support, good lifestyle, and stable
economics were likely protective factors on survival for
married women with cancer in the previous studies (6, 9,
10, 28). However, other recent studies indicated that
social support and social network had a more important
role in reduced mortality for breast cancer, and that
support received from social networks improved survival
in unmarried women (29, 30). The marital status alone
had no significant influence on longer survival of women
with breast cancer (3133). In the context of Vietnam,
married women, especially women with many children,
often faced difficult economic circumstances. The finan-
cial burden of the treatment course for breast cancer
could be a barrier to seeking care and to appropriate
treatment compliance, more importantly, when patients
must pay out of their pockets for health care services.
This may contribute to the higher mortality of breast
cancer among married women in this study. In this
Fig. 2. The extended Cox model assessing the effect of characteristics of patients on mortality from breast cancer.
Table 5. Subgroup analysis of potential prognostic factors
Prognostic factors Hazard ratio p 95% CI
Marital status
Unmarried 1 (baseline)
Married 1.53 0.030 1.042.24
Hormone therapy
No 1 (baseline)
Yes 0.24 0.000 0.130.44
Education level*
Illiterate 1 (baseline)
Primary school 1.00 0.974 0.831.20
Secondary school 0.95 0.571 0.781.14
High school 0.79 0.020 0.640.96
Higher 0.79 0.046 0.620.99
Stage at diagnosis*
Stage I 1 (baseline)
Stage II 1.24 0.060 0.991.56
Stage III 1.64 0.000 1.292.09
Stage IV 2.27 0.000 1.712.99
Hormone therapystage** 1.07 0.053 0.991.14
95% CI: 95% confidence interval for hazard ratio.
*Variables continuously vary with respect to time.
**Interaction terms defined as the product of hormone therapy
and stage at diagnosis.
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situation, universal coverage of health insurance should
be promoted in Vietnam. Besides, the government budget
to support vulnerable groups in health care expenditure
should include cancer patients for whom the cost exceeds
their ability to pay. This combination would encourage
the patients in compliance with their long-term treatment
and thus contribute to reducing deaths from cancers,
including breast cancer.
The association between education level and survival
rate of breast cancer was inconsistent across studies
around the world (6, 12, 34). Generally, our study found a
positive effect of education level on survival for breast
cancer patients. The higher the level of education, the
lower the risk of death due to breast cancer. This finding
may reflect increasing knowledge and awareness of the
disease; appropriate accessibility to health services; and
good compliance to treatment and clinical follow-up by
the higher education groups (6, 12). As mentioned earlier,
the limited awareness and knowledge of cancer at the
community level has been common in Vietnam (27). It
is necessary to educate the public on breast health.
The communication should be relevant to all subjects
for the purposes of early detection of breast cancer,
prevention of breast cancer, and prevention of death from
the disease.
The final prognostic factor found in the study was
hormone therapy within a 5-year treatment course. This
therapy reduced the risk of death among breast cancer
patients in the study population, in accordance with
previous reports (35, 36). The effect of hormone therapy
on survival improvement was often mentioned along with
the influence of hormone receptors. An overview of
randomized trials indicated that Tamoxifen was more
effective in ER-positive than in ER-negative women (36).
More importantly, Crowe et al. concluded that the
presence of these hormonal factors impacted on longer
survival for breast cancers (37). Prior studies in Vietnam
found inconsistent effects of hormone receptors on
prolonging survival time of women with breast cancer.
However, all patients in these studies were taking hor-
mone therapy during their treatment course (17, 18). It is
difficult to identify the role of hormone therapy or
hormone receptors as independent prognostic factors. A
study by Caldarola et al. reported no significant relation-
ship between ER or PR and improved survival (38). In our
study, some of the patients had unknown hormonal
receptors because the assay techniques used for ER/PR
testing were not available in Hue Central Hospital before
2006. They were prescribed hormone therapy based on the
experience of specialized doctors (personal communica-
tion, Dr. Nguyen Dinh Tung, Oncology Department, Hue
Central Hospital). The greatest improvement in survival
from breast cancer of hormonal therapy in our study (HR:
0.22) was strong enough to confirm this as an independent
prognostic factor. Moreover, the presence of hormone
therapy reduced the effect of stage on the risk of death
from breast cancer (HR of interaction term: 1.08).
A number of limitations should be considered when
interpreting the findings of this study. The high propor-
tion of patients lost to follow-up (40.2%) and their
exclusion from the survival analysis may have resulted in
selection bias although their characteristics did not differ
from those included in the analysis. The data were
collected over the period 20012006 and do not reflect
current utilization of advanced treatment methods and
new medications for breast cancer treatment, which could
affect the opportunity to improve survival probability in
the study population. Moreover, diagnosis of breast
cancer in the study population was defined as the time
when patients presented at hospitals for primary treat-
ment, so the lead-time bias could be a potential problem.
The risk of recall bias can occur with information on
education level and hormone therapy following primary
treatment. Although the study population was representa-
tive for two big cities in Vietnam with different char-
acteristics in socioeconomics and epidemiology of breast
cancer, the generalizability of the study findings should be
considered. The presence of high level hospitals might
increase accessibility and availability of relevant treat-
ment; the survival time estimates of our study could be
better than those in other areas of the country where diag-
nosis and treatment techniques varied (15, 22). Despite
these limitations, this is the first population-based survival
analysis for breast cancer in Vietnam. Risk factors on
mortality of breast cancer were identified. The results will
contribute important information to cost-effectiveness
analysis of interventions for breast cancer and will help
health policy makers engaged in planning for programs to
reduce breast cancer mortality. Among the risk factors,
stage at diagnosis showed a strong relation to mortality on
breast cancer. Developing early detection strategies for
breast cancer to shift the stage at presentation to more
favorable early stages is necessary to improve the life
expectancy of women with breast cancer in Vietnam.
Breast cancer education and awareness should be sup-
ported hand-in-hand with early detection programs. The
poorest prognosis on survival time of married women with
breast cancer suggested that financial support policies are
needed to promote access of women, especially poor
women, to appropriate diagnosis and treatment. Besides,
the most important factor to achieve the goal of reducing
breast cancer mortality is that infrastructure, equipment,
and human resources for diagnosis and breast cancer
treatment should be made available, accessible, and
affordable to women in whom early detection strategies
identify breast cancer. Overall, these recommendations
are drawn from the evidence found in the study. Decisions
about these policies should consider the available re-
sources in the country and should also inform directions
for future plans.
Survival probability and prognostic factors for breast cancer mortality
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Conclusion
The survival probability of breast cancer patients in
Vietnam decreased over time following diagnosis. Five-
year survival rate was lower than that in other countries
with similar distributions of stage at diagnosis. Married
status, late stage at diagnosis, low education level, and
lack of hormone therapy were prognostic factors for
higher mortality of women with breast cancer. An early
detection program with support policies could reduce
breast cancer mortality in Vietnam.
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